BIVDA Press Releases

30Nov

BIVDA Press Release - Medicines and Diagnostic Manufacturing Transformation Fund

BIVDA Chief Executive Doris-Ann Williams has commented on the launch of the Medicines and Diagnostic Manufacturing Transformation Fund.

 

“We welcome the announcement of the Medicines and Diagnostic Manufacturing Transformation Fund by the Prime Minister today.

 

The lessons the country has learned during this difficult year in pandemic response must not be forgotten, and the innovations should be used to improve our diagnostic testing system for non-COVID illnesses including cancer, hepatitis and diabetes, to name but a few.

 

Last week we wrote to the Prime Minister on behalf of BIVDA members outlining the critical role they have played in scaling up our testing capacity, and we hope that Mr Johnson will recognise the need to involve British in-vitro diagnostic companies in the implementation of this fund.”

 

ENDS

For more information please contact BIVDA External Affairs Manager Jon Harrison jonh@bivda.org.uk 

Related

NHS could save nearly £7 billion through quick adoption of new diagnostic techniques

London, UK – Research commissioned by Innovate UK and the British In Vitro Diagnostics Association ...

Read More >

IVD Industry Launches 2017 General Election Manifesto

Increasing the adoption of in vitro diagnostics (IVDs) should be a priority for the next Government,...

Read More >

Government Responds to AAR Report – BIVDA’s View

The Government has today (04 November) published its response to the final report of the Accelerated...

Read More >

BIVDA Launches Vision for Increasing Access to Molecular Diagnostics

A new report from the British In Vitro Diagnostics Association (BIVDA) has called for NHS England to...

Read More >

UK continues to lag behind the European market for in-vitro diagnostic expenditure

IVD Market Statistics Report 2017 highlights differences in total healthcare expenditure and wide va...

Read More >